Pathway Background and Objectives
Over the years, the increase in resistance to typical antibiotics has changed the approach to the management of skin and soft tissue infections (SSTIs) in children. In 2014, the Infectious Disease Society of America (IDSA) updated their SSTIs guidelines. Based on these changes and also our local antimicrobial data, we have applied these recommendations to provide a consistent approach to treatment of children with these infections.
The specific objectives of this pathway are to:
- Outline the management of SSTIs depending on severity of infection
- Recommend tailored antibiotic therapy based on culture results
- Recommend oral options for intravenous antibiotics